Study S000014

Glycaemic and Cardiovascular Efficacy of Liraglutide in Prediabetic Patients With End-stage Renal Disease

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02284230
Acronym: LiRA2
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: WITHDRAWN
Enrollment: 0
Start: 2014-12
Primary completion: 2015-08
Lead sponsor: Bo Feldt-Rasmussen
Conditions: Kidney Failure, Chronic; Prediabetic State
Interventions: DRUG:Liraglutide; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Plasma glucose during oral glucose tolerance test at week 26 [The trial visit of week 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.